Implantable cardioverter defibrillators for primary prevention in cardiomyopathies

CONCLUSIONS: When implanted for primary prevention in patients with cardiomyopathies over a mean period of 4.4 ± 3.1 years, appropriate ICD therapy was delivered in 32% patients. However, inappropriate therapy (14% patients) and complications (16% patients) were also common.PMID:38521121 | DOI:10.1016/j.ihj.2024.03.005

Source: Indian Heart J - March 23, 2024 Category: Cardiology Authors: Vineetha Kanneganti Ajay Bahl Manoj Kumar Rohit Saurabh Mehrotra Source Type: research